{
  "docId": "019de072-118b-7459-8ccb-22724833fcd4",
  "docSlug": "04de07fbea9eadeda44cc99f91069101",
  "documentTitle": "AbCellera | Results Presentation Deck | 21 slides",
  "authorId": "abcellera",
  "authorName": "AbCellera",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-02-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 7,
  "pageCount": 21,
  "prevPage": 6,
  "nextPage": 8,
  "slideType": "revenue_buildup",
  "function": "quantify_opportunity",
  "density": "overcrowded",
  "nDataPoints": 3,
  "notes": "The chart uses a stacked bar approach to show revenue components over time, with specific callouts for total values of research fees, clinical milestones, and royalties.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de072-118b-7459-8ccb-22724833fcd4/7",
  "deckHref": "/decks/019de072-118b-7459-8ccb-22724833fcd4",
  "deckJsonHref": "/decks/019de072-118b-7459-8ccb-22724833fcd4.json",
  "deckAnchorHref": "/decks/019de072-118b-7459-8ccb-22724833fcd4#slide-7",
  "components": [
    {
      "bbox": {
        "h": 0.15,
        "w": 0.12,
        "x": 0.77,
        "y": 0.31
      },
      "kind": "callout",
      "text": "royalties in aggregate of $765 million",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "02ae43b3-06a3-4f5d-8703-3f88f0454702",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.14,
        "x": 0.35,
        "y": 0.61
      },
      "kind": "callout",
      "text": "clinical milestones $9 million",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "12a605bb-1b9a-45e1-80d1-a75d7126b794",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.12,
        "x": 0.21,
        "y": 0.64
      },
      "kind": "callout",
      "text": "research fees $3 million",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "853671fc-cfe3-44df-928a-690f8fbcdb0e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.15,
        "x": 0.55,
        "y": 0.41
      },
      "kind": "callout",
      "text": "approval & commercial milestones $85 million",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e118bda5-760f-4ad2-9dcf-98d9a5ff10c5",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.45,
        "w": 0.85,
        "x": 0.107,
        "y": 0.45
      },
      "kind": "chart",
      "text": "Revenue timeline chart",
      "attrs": null,
      "subkind": "bar-stacked",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4e3247cf-4100-4d3b-8871-d3990c446543",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.45,
        "x": 0.107,
        "y": 0.26
      },
      "kind": "paragraph",
      "text": "AbCellera participation in programs is strongly weighted towards downstream success.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "60911cbb-6fc6-48b3-b63d-dae3754e4a26",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.23,
        "x": 0.74,
        "y": 0.07
      },
      "kind": "subtitle",
      "text": "Key Assumptions, hypothetical: $1.7 billion peak sales, no price inflation, no patient population growth, 5% royalty, 6 years to peak sales, 5 years at peak sales, US approval only",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5f8f6a89-a57c-496f-9496-30d7b0dc727f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.65,
        "x": 0.107,
        "y": 0.075
      },
      "kind": "title",
      "text": "ILLUSTRATIVE REVENUE PROFILE FOR ONE SUCCESSFUL PARTNERED PROGRAM.",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3f09cf2c-40a1-4d38-95cd-e8b6b68dbd2d",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 13,
      "from": 7,
      "beatId": "bf52f0f4-f71c-45d7-83ba-6d61d5147353",
      "arcName": "Monroe's Motivated Sequence",
      "arcSlug": "monroes-sequence",
      "beatName": "Satisfaction",
      "beatSlug": "monroes-sequence-satisfaction",
      "evidence": "The presentation showcases the company's strong growth in royalty rates, flexible deal structures, and advancements in GPCRs, ion channels & bispecific antibodies.",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Turn",
      "parentBeatSlug": "turn"
    }
  ],
  "loops": [
    {
      "to": 13,
      "from": 4,
      "name": "Golden Circle",
      "slug": "11-golden-circle",
      "bestFor": "Visionary leadership, brand positioning, mission statements",
      "matchId": "c116a9b9-66b9-474f-8411-60fed0150046",
      "evidence": "The presentation explains the company's technology and its applications.",
      "position": 0,
      "objective": "Why AbCellera's technology is important for antibody discovery",
      "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
      "confidence": 0.7,
      "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
    },
    {
      "to": 13,
      "from": 7,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "18b38177-33a6-4a4b-86ec-5de8ccd482e5",
      "evidence": "The presentation highlights the benefits of partnering with AbCellera.",
      "position": 1,
      "objective": "The potential consequences of not partnering with AbCellera",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.6,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}